Articles From: Fund Statistics Now Available for: Dreyfus Municipal Bond Infrastructure Fund, Inc. to Furiex Pharmaceuticals Announces Management Changes


2013/9/12
Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) announced that certain fund statistics, as of August 31, 2013, are now available.
Sign-up for Fund Statistics Now Available for: Dreyfus Municipal Bond Infrastructure Fund, Inc. investment picks
2013/10/29
Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) announced that certain fund statistics, as of September 30, 2013, are now available.
Sign-up for Fund Statistics Now Available for: Dreyfus Municipal Bond Infrastructure Fund, Inc. investment picks
Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) announced that certain fund statistics, as of October 31, 2013, are now available.
Sign-up for Fund Statistics Now Available for: Dreyfus Municipal Bond Infrastructure Fund, Inc. investment picks
2013/12/23
Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) announced that certain fund statistics, as of November 30, 2013, are now available.
Sign-up for Fund Statistics Now Available for: Dreyfus Municipal Bond Infrastructure Fund, Inc. investment picks
2014/1/21
Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) announced that certain fund statistics, as of December 31, 2013, are now available.
Sign-up for Fund Statistics Now Available for: Dreyfus Municipal Bond Infrastructure Fund, Inc. investment picks
2014/2/26
Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) announced that certain fund statistics, as of January 31, 2014 are now available.
Sign-up for Fund Statistics Now Available for: Dreyfus Municipal Bond Infrastructure Fund, Inc. investment picks
2014/3/17
Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) announced that certain fund statistics, as of February 28, 2014 are now available.
Sign-up for Fund Statistics Now Available for: Dreyfus Municipal Bond Infrastructure Fund, Inc. investment picks
2014/2/4
Worst Month since May 2012 NEW YORK , Feb.
Sign-up for Funded Status of U.S. Corporate Pensions Falls to 91.0 Percent, According to BNY Mellon ISSG investment picks
2014/4/2
Public Plans, Foundations and Endowments also Lose Ground NEW YORK , April 2, 2014 /PRNewswire/ -- The funded status of the typical U.S. corporate pension plan declined 0.5 percentage points in March 2014 to 92.1 percent as liabilities increased faster than assets, according to the BNY Mellon Investment Strategy & Solutions Group (ISSG).    The BNY Mellon Institutional Scorecard for March noted liabilities rose 0.7 percent, outpacing the 0.3 percent increase in assets during the month.
Sign-up for Funded Status of U.S. Corporate Pensions Falls to 92.1 Percent, According to BNY Mellon ISSG investment picks
2013/8/5
Public Plans and Foundations and Endowments Also Gain BNY Mellon Introduces Institutional Scorecard NEW YORK , Aug.
Sign-up for Funded Status of U.S. Corporate Pensions Rises to 88.2 Percent in July, according to BNY Mellon ISSG investment picks
Public Pension Plans, Endowments and Foundations Exceed Targets as Equities Rise NEW YORK , Oct.
Sign-up for Funded Status of U.S. Corporate Pensions Rises to 91.0 Percent in September, according to BNY Mellon ISSG investment picks
2013/11/4
Public Pension Plans, Endowments and Foundations Also Benefit from Improving Markets NEW YORK , Nov.
Sign-up for Funded Status of U.S. Corporate Pensions Rises to 91.8 Percent in October, according to BNY Mellon ISSG investment picks
2014/3/5
Public Plans, Foundations and Endowments also Gain NEW YORK , March 5, 2014 /PRNewswire/ -- The funded status of the typical U.S. corporate pension plan improved 1.7 percentage points in February 2014 to 92.6 percent as most asset classes gained during the month, according to the BNY Mellon Investment Strategy & Solutions Group (ISSG).    The BNY Mellon Institutional Scorecard for February noted the gains in asset values outpaced the rise in liabilities, which resulted from falling interest rates.
Sign-up for Funded Status of U.S. Corporate Pensions Rises to 92.6 Percent, According to BNY Mellon ISSG investment picks
Endowments and Foundations Benefit from Hedge Fund, Private Equity Holdings NEW YORK , Dec.
Sign-up for Funded Status of U.S. Corporate Pensions Rises to 93.9 Percent in November, according to BNY Mellon ISSG investment picks
Pension Plans, Endowments and Foundations Benefit from Equity Rally NEW YORK , Jan.
Sign-up for Funded Status of U.S. Corporate Pensions Rises to 95.2 Percent in December, according to BNY Mellon ISSG investment picks
2014/2/11
http://media.marketwire.com/attachments/201205/46590_INgen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1088996&ProfileId=051205&sourceType=1 RIVERSIDE, CA --
Sign-up for Funding Partnership for Business Expansion Program Is Launched as Projected investment picks
Funding Relief Measures for Pension Plans in Quebec and Regulation Changes for Retirement Savings Accounts in Ontario Canada NewsWire These are among the subjects included in the current issue of the Morneau Shepell News & Views, a monthly publication dedicated to providing insights to its clients in Canada TORONTO , Aug.
Sign-up for Funding Relief Measures for Pension Plans in Quebec and Regulation Changes for Retirement Savings Accounts in Ontario investment picks
rue21, inc.
Sign-up for Funds Advised by Apax Partners Complete Acquisition of rue21 investment picks
Donation to Assist Teachers in Purchasing School Supplies for Their Classrooms MINNEAPOLIS , Nov.
Sign-up for Funds Raised by JCPenney Allow AdoptAClassroom.org to Distribute More Than $1 Million to Teachers Nationwide investment picks
By Patrick Fitzgerald A Delaware bankruptcy judge's recent ruling that the former parent of a failed California thrift has top claim on a $374 million tax refund is a win for investors picking over the remnants of the hundreds of failed banks left in the wake of the financial crisis.
Sign-up for Funds Say Downey Ruling Boosts Claim to Colonial Tax Refunds investment picks
Corporate Bully Turns Down Teamsters' Offer to Return to Work CHICAGO , Dec.
Sign-up for Funeral Giant SCI Refuses Interest Arbitration To End Five-Month Labor Dispute investment picks
Pickets Continue As Corporate Bully Locks Doors on 59 Funeral Directors, Drivers CHICAGO , Aug.
Sign-up for Funeral Industry Giant SCI Locks Out Chicago Funeral Directors investment picks
2013/11/5
Katsuma Unleashed OUT NOW! NEW YORK , Nov.
Sign-up for Fur Will Fly This Fall As Katsuma Is Unleashed On Nintendo 3DS And Nintendo DS In A Roarsome New Adventure investment picks
2013/9/3
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today confirmed that Takeda Pharmaceutical Company Limited (Takeda) announced top line results of the EXAMINE ( EX amination of C A rdiovascular Outco M es: Aloglipt IN vs.
Sign-up for Furiex Confirms Alogliptin Cardiovascular Safety Outcomes Trial (EXAMINE) Met Primary Endpoint investment picks
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today confirmed Takeda Pharmaceutical Company Limited (Takeda)’s announcement that the European Commission has granted Marketing Authorization (MA) for VIPIDIA™ (alogliptin) for the treatment of Type 2 diabetes patients who are uncontrolled on existing therapies and for the fixed-dose combinations VIPDOMET™ (alogliptin and metformin) and INCRESYNC™ (alogliptin and pioglitazone). The Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMA), issued a positive opinion for these products on July 26, 2013.
Sign-up for Furiex Confirms Takeda Receives European Marketing Authorization for VIPIDIA™ (alogliptin), VIPDOMET™ (alogliptin and metformin) and INCRESYNC™ (alogliptin and pioglitazone) investment picks
2014/4/3
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced that results from its two Phase III clinical trials of eluxadoline in patients with diarrhea-predominant irritable bowel syndrome will be presented in a Late-Breaking Abstract Session at Digestive Disease Week (DDW) 2014, to be held May 3-6 at McCormick Place in Chicago, IL.
Sign-up for Furiex Pharmaceuticals Announces Acceptance to Late-Breaking Abstract Session at Digestive Disease Week 2014 investment picks
2014/4/7
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) will release its first quarter 2014 financial results on Wednesday, May 7, 2014, after the market closes.
Sign-up for Furiex Pharmaceuticals Announces First Quarter 2014 Earnings Release and Conference Call investment picks
2014/2/10
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) will release its fourth quarter 2013 financial results on Tuesday, March 11, 2014, after the market closes.
Sign-up for Furiex Pharmaceuticals Announces Fourth Quarter 2013 Earnings Release and Conference Call investment picks
2013/10/28
Furiex Pharmaceuticals, Inc. (NASDAQ:FURX) announced today the appointment of Sailash Patel to the position of Chief Financial Officer, effective November 15, 2013.
Sign-up for Furiex Pharmaceuticals Announces Management Changes investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Fund Statistics Now Available for: Dreyfus Municipal Bond Infrastructure Fund, Inc. to Furiex Pharmaceuticals Announces Management Changes
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity